Published in J Thromb Haemost on May 01, 2003
Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ (2004) 2.01
Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC Fam Pract (2011) 0.91
Utilization of CT Pulmonary Angiography in Suspected Pulmonary Embolism in a Major Urban Emergency Department. Pulm Med (2013) 0.78
Appropriate use of D-dimer testing can minimize over-utilization of venous duplex ultrasound in a contemporary high-volume hospital. Ann Vasc Surg (2014) 0.75
Evaluation of the Simplify D-dimer assay as a screening test for the diagnosis of deep vein thrombosis in an emergency department. Emerg Med J (2004) 0.75
ACCESS: the acute cerebral CT evaluation stroke study. Emerg Med J (2004) 0.75
Images in clinical medicine. Heparin-induced skin necrosis. N Engl J Med (1996) 3.30
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Hyperhomocysteinaemia as a cardiovascular risk factor: an update. Neth J Med (2000) 2.47
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
[Simplified diagnosis of deep venous thrombosis by applying clinical score and D-dimer concentration]. Ned Tijdschr Geneeskd (2003) 2.02
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Graft-versus-myeloma effect in two cases. Lancet (1996) 1.80
Nocardiosis: a case series and a mini review of clinical and microbiological features. Neth J Med (2007) 1.54
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis (1993) 1.45
[Sigmoid carcinoma as a long-term complication following ureterosigmoidostomy]. Ned Tijdschr Geneeskd (2008) 1.43
[Unexplained vague abdominal complaints in adults: indication for CT in case of suspected intussusception]. Ned Tijdschr Geneeskd (2003) 1.42
[Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary]. Ned Tijdschr Geneeskd (2003) 1.42
How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis (2001) 1.41
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
Sequential regulation of the small GTPase Rap1 in human platelets. Mol Cell Biol (2000) 1.32
Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation (2003) 1.28
The origin of P-selectin as a circulating plasma protein. Thromb Haemost (1997) 1.25
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Determinants of patient satisfaction after cataract surgery in 3 settings. J Cataract Refract Surg (2000) 1.21
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Systemic cytokine response in patients with community-acquired pneumonia. Eur Respir J (2010) 1.19
Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood (1987) 1.18
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology (2001) 1.11
Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke (1997) 1.11
Clinical severity of haemophilia A: does the classification of the 1950s still stand? Haemophilia (2011) 1.07
Cardiovascular disease in patients with hemophilia. J Thromb Haemost (2008) 1.04
Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost (1996) 1.03
Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol (2001) 1.02
Iron metabolism and erythropoiesis after surgery. Br J Surg (1998) 1.01
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood (1997) 0.98
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost (1987) 0.97
Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol (2009) 0.97
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res (2009) 0.97
Clinical relevance of the methionine loading test for assessment of hyperhomocysteinaemia. Neth J Med (2000) 0.96
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest (1994) 0.96
Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol (1997) 0.95
Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling. Arterioscler Thromb Vasc Biol (1999) 0.94
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. Eur J Haematol (1997) 0.92
Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. Eur Respir J (2011) 0.92
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine (2001) 0.91
The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost (2001) 0.90
Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood (1995) 0.90
Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost (2010) 0.89
Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut (1990) 0.89
Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees. Leukemia (2012) 0.89
Platelet adhesion to collagen. Thromb Haemost (1995) 0.89
Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost (1996) 0.88
A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol (1992) 0.88
Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Expression of GMP-140 and LIMP-CD63 (CD63 antigen) in human lymphoid tissues. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.88
The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism. Ann Oncol (2008) 0.88
Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost (1991) 0.88
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science (1987) 0.86
Primary non-Hodgkin's lymphoma of the cranial vault; MRI features before and after treatment. Clin Radiol (2002) 0.86
A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group. Blood (1993) 0.86
Thrombocytopenia and the neglected megakaryocyte. N Engl J Med (1992) 0.86
Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Hum Genet (2000) 0.86
Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine (2010) 0.86
Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases. Diabet Med (2012) 0.84
Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study. Circulation (1989) 0.83
Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine (2008) 0.83
MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents. J Clin Oncol (1994) 0.83
Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med (1998) 0.83
Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes (1995) 0.83
Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation. Transpl Infect Dis (2004) 0.82
Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A. Thromb Haemost (1994) 0.82
Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion (1990) 0.82
[Breast cancer in southeast North Brabant and in North Limburg; trends in incidence and earlier diagnosis in an unscreened female population, 1975-1986]. Ned Tijdschr Geneeskd (1990) 0.82
Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions. Blood (1993) 0.82
Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood (1991) 0.81
Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood (1994) 0.81
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells. Bone Marrow Transplant (1998) 0.81
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transplant (1999) 0.81
Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial. Neth Heart J (2007) 0.81
Platelet adhesion to collagen type IV under flow conditions. Blood (1996) 0.81
Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon. Bone Marrow Transplant (2007) 0.80
Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med (1993) 0.80
ATP-ADP compartmentation in storage pool deficient platelets: correlation between granule-bound ADP and the bleeding time. Br J Haematol (1983) 0.80
Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med (1987) 0.80
The effect of red cell transfusion on nitric oxide diffusing capacity. Respiration (2005) 0.80
Joint distraction results in clinical and structural improvement of haemophilic ankle arthropathy: a series of three cases. Haemophilia (2012) 0.80
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux. J Thromb Haemost (2003) 0.80
Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol (2011) 0.80
Detection of platelet activation using activation specific monoclonal antibodies. Blood Cells (1990) 0.80
Harmonization of fibrinogen assay results: study within the framework of the Dutch project 'Calibration 2000'. Int J Lab Hematol (2008) 0.80
Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine (2007) 0.79
Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements. Haemophilia (2011) 0.79
Primary extranodal CD3O-positive T-cell non-Hodgkins lymphoma of the oral mucosa. Report of two cases. Int J Oral Maxillofac Surg (1996) 0.79
Identification and expression of iron regulators in human synovium: evidence for upregulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controls. Haemophilia (2013) 0.79
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. J Clin Invest (1987) 0.79